Literature DB >> 20737602

Molecular characterization of sickle cell anemia in the Northern Brazilian state of Pará.

Greice De Lemos Cardoso1, João Farias Guerreiro.   

Abstract

To assess alpha+-thalassemia deletion alleles, beta-thalassemia mutations and haplotypes linked to the HBB*S cluster in a sample of 130 unrelated sickle cell anemia (SCA) patients (55% female) from Belém, Pará State, for their possible effects on the patients' survival. -alpha(3.7), -alpha(42), -alpha(20.5), and -(MED) alpha+-thalassemia deletion alleles were investigated using multiplex gap-PCR method. Characterization of beta-thalassemia mutations was made by direct genomic sequencing of the beta-globin gene amplified through polymerase chain reaction (PCR). Haplotypes were determined by analysis of six polymorphic restriction sites [(1) XmnI-5'gammaG, (2) HindIII-gammaG, (3) HindIII-gammaA, (4) HincII-psibeta, (5) HincII-3'psibeta, and (6) HinfI-5'beta] followed by restriction digestion and agarose gel electrophoresis. Twenty-one patients (16%) presented -alpha3.7 thalassemia. Sixteen of those (76%) were heterozygous (-alpha3.7/alphaalpha) and 5 (24%) were homozygous (-alpha3.7/-alpha3.7). -Alpha(4.2), -alpha(20.5) and -(MED) deletions were not found. Nine cases of sickle cell-beta thalassemia were found and four different beta-thal mutations were identified: beta(+) -88 (C>T), 3.8%; beta(+) codon 24 (T > A), 1.5%; beta(+) IVSI-110 (G > A), 0.7% and beta (IVSI-1 (G > A), 0.7%. No differences according to age were observed in -alpha(3.7) deletion, beta-thalassemia and HHB*S haplotypes distribution. Our results suggest that although alpha- and beta-thalassemia and betaS haplotypes may have modulating effect on clinical expression and hematological parameters of SCA, these genetic variables probably have little influence on the subjects' survival. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20737602     DOI: 10.1002/ajhb.21047

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  5 in total

1.  Influence of alpha thalassemia on clinical and laboratory parameters among nigerian children with sickle cell anemia.

Authors:  Oladele S Olatunya; Dulcineia M Albuquerque; Adekunle Adekile; Fernando F Costa
Journal:  J Clin Lab Anal       Date:  2018-08-20       Impact factor: 2.352

Review 2.  Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Authors:  Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Paediatr Respir Rev       Date:  2013-11-15       Impact factor: 2.726

3.  Haplotype of the β(S)-globin cluster in patients with sickle cell anemia at a University Hospital in the Triangulo Mineiro, Minas Gerais.

Authors:  Alexandra Silva Leal; Paulo Roberto Juliano Martins; Marly Aparecida Spadotto Balarin
Journal:  Rev Bras Hematol Hemoter       Date:  2015-02-02

4.  Molecular analysis and association with clinical and laboratory manifestations in children with sickle cell anemia.

Authors:  Roberta Faria Camilo-Araújo; Olga Maria Silverio Amancio; Maria Stella Figueiredo; Ana Carolina Cabanãs-Pedro; Josefina Aparecida Pellegrini Braga
Journal:  Rev Bras Hematol Hemoter       Date:  2014-07-09

5.  The importance of hemoglobin A2 determination.

Authors:  Maria Stella Figueiredo
Journal:  Rev Bras Hematol Hemoter       Date:  2015-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.